Stocks
Edwards Lifesciences (EW) EBITDA margin US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 36.1% | 36.4% | 30.6% | 31.7% | 23.6% | 22.8% | ||
| Changes by years, y/y, % | +12pp | +0pp | -6pp | +1pp | -8pp | -0.8% | |||
Edwards Lifesciences. EBITDA margin, %
Edwards Lifesciences. EBITDA margin, changes, pp
Edwards Lifesciences (EW) EBITDA margin US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 33.3% | 26.1% | 25.0% | 8.48% | 31.2% | 22.8% | |
| Changes by years, y/y, % | +2pp | -5pp | -7pp | -26pp | -2pp | |||
| Changes by quarters, q/q, % | -2pp | -7pp | -1pp | -16pp | +23pp | |||
